Lundbeck initiates schizophrenia studies Hays Pharma, UK - Global rights to the compound were acquired by Lundbeck from US biotechnology firm Saegis Pharmaceuticals in early-2007. "I'm very pleased that we're able ... |
February 2009
Hoover
« Global Biotechnology - http://www.companiesandmarkets.com adds new ... - Live-PR.com (Pressemitteilung) | Main | REAL ESTATE: Report sees rising office vacancies in 2009 - North County Times »
December 17, 2008
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00e54ed2f12088330105367d046e970b
Listed below are links to weblogs that reference Lundbeck initiates schizophrenia studies - Hays Pharma:
Verify your Comment
Previewing your Comment
This is only a preview. Your comment has not yet been posted.
Your comment could not be posted. Error type:
Your comment has been posted. Post another comment
As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.
Having trouble reading this image? View an alternate.
Comments